Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

May 23, 2014

OTSUKA PHARMACEUTICAL CO., LTD. v. AUROBINDO PHARMA LIMITED et al

Track this case

Case Number:

1:14-cv-03306

Court:

New Jersey

Nature of Suit:

Patent

Judge:

Jerome B. Simandle

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. May 27, 2014

    Otsuka Sues Aurobindo To Halt Generic Abilify

    Otsuka Pharmaceutical Co. Ltd. filed suit Friday against Aurobindo Pharma Ltd. and its subsidiaries in New Jersey federal court, alleging Aurobindo's bid to market a generic version of its bipolar disorder, depression and schizophrenia medication Abilify violates its patents.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login